Biontech

265 results

Covid-19 cases soared in October and early November, setting daily records in the United States and Europe.

Drugmakers and research centres around the world are working on Covid-19 vaccines, with large global trials of several of the candidates involving ten(...)

Pedestrians pass shuttered shops in Derry. The Northern Executive is to meet again on Tuesday to  discuss whether to extend the current four-week lockdown by another two weeks. Photograph: Bloomberg

The Northern Executive after two meetings on Monday was unable to agree on whether to extend the current four-week lockdown that is due to end on Fri(...)

Associated British Foods, the owner of the Irish-headquartered discount fashion chain Penneys/Primark, was up by almost 17 per cent in early afternoon trading.

Hospitality stocks, such as airlines and hotel operators, as well as retailers surged on the news that a potential vaccine for coronavirus may be up t(...)

For the vaccine to work, two doses that are taken three weeks apart will be needed. Photograph: EPA/RONALD WITTEK / ANDREW GOMBERT

Positive data on BioNTech and US partner Pfizer’s COVID-19 vaccine is an unlikely success for the married couple behind the German biotech firm, who (...)

The drug is expected to be submitted to authorities for emergency approval in the third week of November, ahead of other vaccine developers. Photograph: Nick Bradshaw

A Covid-19 vaccine being developed by Pfizer and Germany’s BioNTech has been found to be more than 90 per cent effective, in a breakthrough that could(...)

The race for a coronavirus vaccine has stoked a debate on how much the jabs will cost and who will pay for them.

The race for a coronavirus vaccine has stoked a debate on how much the jabs will cost and who will pay for them, as prices range from $3 to more than (...)

The Pfizer vaccine is being tested on  38,000 people worldwide. Photograph: Jakub Porzycki/NurPhoto via Getty Images

Pfizer will apply for emergency US approval of the Covid-19 vaccine it is developing with Germany’s BioNTech in the third week of November, the pharma(...)

Paul Reid of Pfizer is taking over as head of industry body Ipha. Photograph: Dara Mac Dónaill / The Irish Times

“What we want to do is correct the innovation paradox...” It’s a bad start to an interview and a raised eyebrow persuades Paul Reid to explain the man(...)

Greencoat Renewables shed 1.68 per cent of its value to close at €1.17. Photograph: Dara Mac Dónaill

World stock markets rose yesterday on encouraging signs of progress in developing a Covid-19 vaccine, while several multibillion-dollar deals also hel(...)

The difficulty for vaccine makers is that even clinical trials involving 30,000 people – such as AstraZeneca’s current phase 3 trial – may not pick up rare, but potentially devastating, reactions. Photograph: iStock

When AstraZeneca confirmed on Tuesday evening that it had temporarily halted trials of its coronavirus vaccine, the news disconcerted millions around(...)

  • « First
  • Prev
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • Next
  • Last »